Rama Rao Tadikonda

Prof. Rama Rao Tadikonda

Pharmacy, CMR College of Pharmacy, Hyderābād, Telangana, International
orcid
Professor and Principal, Hyderabad

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
Naveen ChellaNaveen Chella
Naveen Chella
NSNalini R Shastri
Nalini R Shastri
Rama Rao TadikondaRama Rao Tadikonda
Rama Rao Tadikonda
The aim of this study was to improve the dissolution rate of the poorly soluble drug valsartan by delivering the drug as a liquisolid compact. Liquisolid compacts were prepared using propylene glycol as solvent, Avicel PH102 as carrier, and Aerosil 200 as the coating material. The crystallinity of the newly formulated drug and the interaction between excipients was examined by X-ray powder diffraction and Fourier-transform infrared spectroscopy, respectively. The dissolution studies for the liquisolid formulation and the marketed product were carried out at different pH values. The results showed no change in the crystallinity of the drug and no interaction between excipients. The dissolution efficiency of valsartan at 15min was increased from 4.02% for plain drug and 13.58% for marketed product to 29.47% for the liquisolid formulation. The increase in the dissolution rate was also found to be significant compared to the marketed product at lower pH values, simulating the gastric environment where valsartan is largely absorbed. The liquisolid technique appears to be a promising approach for improving the dissolution of poorly soluble drugs like valsartan

25 November 2010 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
umasankar kulandaiveluumasankar kulandaivelu
umasankar kulandaivelu
VPValisakka Gari Padmini
Valisakka Gari Padmini
KSKyatham Suneetha
Kyatham Suneetha
BSBoyapati Shireesha
Boyapati Shireesha
JVJannu Vincent Vidyasagar
Jannu Vincent Vidyasagar
VJVenkatesan Jayaprakash
Venkatesan Jayaprakash

12 October 2014 in Journal of Drug Delivery
Verified
Journal Article
Open access
PDF file
Naveen ChellaNaveen Chella
Naveen Chella
NNNataraj Narra
Nataraj Narra
Rama Rao TadikondaRama Rao Tadikonda
Rama Rao Tadikonda
The objective of the present work was to obtain pH independent and improved dissolution profile for a poorly soluble drug, telmisartan using liquisolid compacts. Liquisolid compacts were prepared using Transcutol HP as vehicle, Avicel PH102 as carrier, and Aerosil 200 as a coating material. The formulations were evaluated for drug excipient interactions, change in crystallinity of drug, flow properties, and general quality control tests of tablets using Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), X-ray diffraction (XRD), angle of repose, and various pharmacopoeial tests.In vitrodissolution studies were performed at three pH conditions (1.2, 4.5 and 7.4). Stability studies were performed at 40°C and 75% RH for three months. The formulation was found to comply with Indian pharmacopoeial limits for tablets. FTIR studies confirmed no interaction between drug and excipients. XRD and DSC studies indicate change/reduction in crystallinity of drug. Dissolution media were selected based on the solubility studies. The optimized formulation showed pH independent release profile with significant improvementP<0.005in dissolution compared to plain drug and conventional marketed formulation. No significant difference was seen in the tablet properties, and drug release profile after storage for 3 months.

21 July 2014 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PDF file
BDBhaskar Daravath
Bhaskar Daravath
Rama Rao TadikondaRama Rao Tadikonda
Rama Rao Tadikonda
Sateesh Kumar VemulaSateesh Kumar Vemula
Sateesh Kumar Vemula
Context: Development of solid dispersions is to improve the therapeutic efficacy by increasing the drug solubility, dissolution rate, bioavailability as well as to attain rapid onset of action. Objective: The present research deals with the development of solid dispersions of flurbiprofen which is poorly water soluble to improve the solubility and dissolution rate using gelucires. Materials and methods: In this study, solid dispersions were prepared following solvent evaporation method using gelucire 44/14 and gelucire 50/13 as carriers in different ratios. Then the formulations were evaluated for different physical parameters, solubility studies, DSC, FTIR studies and in vitro dissolution studies to select the best formulation that shows rapid dissolution rate and finally subjected to pharmacokinetic studies. Results and discussion: From the in vitro dissolution study, formulation F3 showed the better improvement in solubility and dissolution rate. From the pharmacokinetic evaluation, the control tablets produced peak plasma concentration (Cmax) of 9140.84 ± 614.36 ng/ml at 3 h Tmax and solid dispersion tablets showed Cmax = 11 445.46 ± 149.23 ng/ml at 2 h Tmax. The area under the curve for the control and solid dispersion tablets was 31 495.16 ± 619.92 and 43 126.52 ± 688.89 ng h/ml and the mean resident time was 3.99 and 3.68 h, respectively. Conclusion: From the above results, it is concluded that the formulation of gelucire 44/14 solid dispersions is able to improve the solubility, dissolution rate as well as the absorption rate of flurbiprofen than pure form of drug.

1 January 2017 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
BDBhaskar Daravath
Bhaskar Daravath
Naveen ChellaNaveen Chella
Naveen Chella
SVSateesh Kumar Vemula
Sateesh Kumar Vemula
Rama Rao TadikondaRama Rao Tadikonda
Rama Rao Tadikonda
The intent of the current work is to study the effect of polyethylene glycol 8000 and polyethylene glycol 10000 as hydrophilic carriers on dissolution behaviour of flurbiprofen. In the present study, solvent evaporation method was used to prepare flurbiprofen solid dispersions and evaluated for physico-chemical properties, drug-carrier compatibility studies and dissolution behaviour of drug. Solubility studies showed more solubility in higher pH values and formulations SD4 and SD8 were selected to prepare the fast dissolving tablets. FTIR and DSC study showed no interaction and drug was dispersed molecularly in hydrophilic carrier. XRD studies revealed that there was change in the crystallinity of the drug. The results of In vitro studies showed SD8 formulation confer significant improvement (p<0.05) in drug release, Q20 was 99.08±1.35% compared to conventional and marketed tablets (47.31±0.74% and 56.86±1.91%). The mean dissolution time (MDT) was reduced to 8.79 min compared to conventional and marketed tablets (25.76 and 22.22 min.) indicating faster drug release. The DE (% dissolution efficiency) was increased by 2.5 folds (61.63%) compared to conventional tablets (23.71%). From the results, it is evident that polyethylene glycol solid dispersions in less carrier ratio may enhance the solubility and there by improve the dissolution rate of flurbiprofen.

10 July 2015 in European Journal of Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
Naveen ChellaNaveen Chella
Naveen Chella
BDBhaskar Daravath
Bhaskar Daravath
Dinesh KumarDinesh Kumar
Dinesh Kumar
Rama Rao TadikondaRama Rao Tadikonda
Rama Rao Tadikonda